500288 Stock Overview
Develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), formulations, and home health products in India, the United States, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Morepen Laboratories Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹75.87 |
| 52 Week High | ₹100.80 |
| 52 Week Low | ₹38.56 |
| Beta | 1.49 |
| 11 Month Change | -11.27% |
| 3 Month Change | 8.77% |
| 1 Year Change | 90.82% |
| 33 Year Change | 52.50% |
| 5 Year Change | 368.33% |
| Change since IPO | -31.65% |
Recent News & Updates
Recent updates
Shareholder Returns
| 500288 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -5.1% | -1.8% | -1.8% |
| 1Y | 90.8% | 41.2% | 27.2% |
Return vs Industry: 500288 exceeded the Indian Pharmaceuticals industry which returned 41.1% over the past year.
Return vs Market: 500288 exceeded the Indian Market which returned 27% over the past year.
Price Volatility
| 500288 volatility | |
|---|---|
| 500288 Average Weekly Movement | 8.0% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.2% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 500288's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: 500288's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 2,152 | Sushil Suri | www.morepen.com |
Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), formulations, and home health products in India, the United States, and internationally. The company offers APIs for anti-histaminic, anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic, anti-coagulant, anti-gout, anti-depressant, and anti-malarial drugs; and home diagnostic products, such as air purifiers, sphygmomanometer, blood glucose test strips, blood pressure monitors, breathe free vaporizers, stethoscopes, digital thermometers, blood glucose monitors, nebulizers, heat belts, and pulse oximeters. It also provides fever X for fever; Pain X for pain; Fiber-X, a sat isabgol; Acidity X for acidity; Burnol, first degree/minor burns cream; and formulations for nutrition and probiotics, gastroenterology, antibiotics, gynecology, anti-allergic, and central nervous system, as well as cardiology, diabetology, and nutraceuticals.
Morepen Laboratories Limited Fundamentals Summary
| 500288 fundamental statistics | |
|---|---|
| Market cap | ₹41.57b |
| Earnings (TTM) | ₹1.31b |
| Revenue (TTM) | ₹17.75b |
31.7x
P/E Ratio2.3x
P/S RatioIs 500288 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 500288 income statement (TTM) | |
|---|---|
| Revenue | ₹17.75b |
| Cost of Revenue | ₹11.10b |
| Gross Profit | ₹6.65b |
| Other Expenses | ₹5.34b |
| Earnings | ₹1.31b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.40 |
| Gross Margin | 37.48% |
| Net Profit Margin | 7.40% |
| Debt/Equity Ratio | 3.0% |
How did 500288 perform over the long term?
See historical performance and comparison